Taito Esaki
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 103
- Cancer Treatment and Pharmacology 45
- Cancer Immunotherapy and Biomarkers 16
- Gastroenterology top 1%
-
- Gastric Cancer Management and Outcomes 73
- Lung Cancer Treatments and Mutations 38
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 14
-
- Genetic factors in colorectal cancer 23
-
- Cancer Genomics and Diagnostics 26
- Co-authors
- Kensei YamaguchiTomohiro NishinaIchinosuke HyodoYoshito KomatsuNarikazu BokuKei MuroToshikazu MoriwakiNaotoshi Sugimoto
- Journals
- New England Journal of Medicine (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (67 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Taito Esaki
177 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 2.1k
- Gastroenterology 377
- Pulmonary and Respiratory Medicine 1.4k
- Hepatology 192
- Pathology and Forensic Medicine 353
Countries citing papers authored by Taito Esaki
This map shows the geographic impact of Taito Esaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taito Esaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taito Esaki more than expected).
Fields of papers citing papers by Taito Esaki
This network shows the impact of papers produced by Taito Esaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taito Esaki. The network helps show where Taito Esaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Taito Esaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 7 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 14 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 17 | |
| 15 | 2019 | 2 | |
| 16 | 2017 | 0 | |
| 17 | 2016 | 11 | |
| 18 | 2016 | 27 | |
| 19 | 2016 | 13 | |
| 20 | 2010 | 1 |
About Taito Esaki
Taito Esaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 184 papers that have together received 3.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (103 papers), Gastric Cancer Management and Outcomes (73 papers), Cancer Treatment and Pharmacology (45 papers), Lung Cancer Treatments and Mutations (38 papers), Cancer Genomics and Diagnostics (26 papers), Genetic factors in colorectal cancer (23 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). The work is most often cited by research in Oncology (2.1k citations), Gastroenterology (377 citations) and Pulmonary and Respiratory Medicine (1.4k citations). Taito Esaki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kensei Yamaguchi, Tomohiro Nishina, Ichinosuke Hyodo, Yoshito Komatsu, Narikazu Boku, Kei Muro, Toshikazu Moriwaki, Naotoshi Sugimoto, Eishi Baba and Akihito Tsuji. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.